Independent. No tobacco money. No corporate fluff.THU, OCT 8

PouchDaily

The daily pulse of the nicotine pouch market

Market
US

On! Pouch Volume Hits 47.2M Cans — But Share Still Falls as ZYN and Velo Outpace Altria's Growth

Altria's On! Plus rollout drove Q2 volume to 47.2 million cans, yet On!'s retail share dropped to 13.9% in H1 2026 (down from 16.8% a year earlier) as the $13.4B pouch category grows faster than On! can capture it.

PouchDaily Desk·
On! Pouch Volume Hits 47.2M Cans — But Share Still Falls as ZYN and Velo Outpace Altria's Growth
On!Altriamarket shareFDA authorizationZYNVeloUnited Statesmarket analysisretail data

Altria shipped 47.2 million cans of On! nicotine pouches in Q2 2026 — a 17% jump from 40.2 million in Q4 2025 — yet On!'s slice of the U.S. pouch market shrank year-over-year. The paradox: volume is climbing because the category is exploding, but On! is losing ground to ZYN and Velo in a three-way race where second place is still up for grabs.

On! held 14.4% of pouch retail share in Q2 2026, up 1.0 percentage point sequentially but down 1.7pp from Q2 2025. Zoom out to the first half of the year and the picture is starker: On!'s H1 2026 share fell from 16.8% to 13.9% — a relative decline of more than 15% — even as the brand's absolute volume grew. The culprit: nicotine pouches now make up 59.9% of the $13.4 billion U.S. oral tobacco category (up 8.1pp YoY), and competitors are capturing that growth faster than Altria.

What Altria Is Betting On

Altria's answer is On! Plus, a lineup that secured FDA marketing authorizations for six products in December 2025 — the first pouch approvals explicitly citing lower harmful constituents versus traditional oral tobacco. The rollout:

  • 12mg strengths: Initial shipments hit Florida, North Carolina, and Texas; nationwide expansion is underway in Q3 2026.
  • New flavors: Blueberry Mint and Mango Pineapple enter the national market in Q4 2026.
  • Future line extensions: Planned for 2027 and beyond, with the December authorizations creating a streamlined PMTA pathway for supplemental reviews.

On! is now in 120,000 retail locations, and brand awareness reached 57% among adult nicotine users aged 21–54 in H1 2026 (up from 53% a year earlier). All of Q2's incremental volume growth — the jump from 40.8 million cans in Q1 to 47.2 million in Q2 — came from On! Plus.

The Market On! Is Chasing

U.S. smokeless tobacco convenience retail hit $13.4 billion for the 52 weeks ending June 14, 2026, up 12.7% year-over-year. Unit volume climbed 10.0% to 1.86 billion units; average unit price rose 2.4% to $7.22. The category is splitting in two:

  • Spitless tobacco (pouches): $7.29 billion (+27.2% YoY), 54.4% dollar share (+6.2pp), unit sales +25.8% to 1.14 billion.
  • Traditional snuff: $5.98 billion (−0.5%), share down 5.9pp to 44.6%.
  • Chewing tobacco: $141 million (−11.3%), barely 1% of the category.

Pouches are eating the oral tobacco world. The question is whether On! can eat faster.

Can On! Catch Up?

Altria has distribution, FDA authorizations, and a product pipeline. What it doesn't have yet is momentum that matches the category's 27% growth rate. On!'s Q2 sequential share gain (14.4%, up from 13.4% in Q1) suggests the On! Plus launch is registering with retailers and consumers — but the year-over-year comparison (down 1.7pp) shows ZYN and Velo are still winning the volume war.

The FDA authorizations matter beyond marketing: they establish a regulatory template that could speed future SKU approvals, letting Altria iterate flavors and formats faster than competitors stuck in multi-year PMTA queues. If the 2027 line extensions land and 12mg strengths pull share from ZYN's high-nic users, On! could stabilize in the #2 spot.

But if Q3 and Q4 repeat the H1 pattern — volume up, share down — Altria will be growing in absolute terms while shrinking in relative terms, a treadmill that ends with On! as a permanent bronze medalist in a category it helped build.

What's Next

  • Q3 2026: Nationwide 12mg rollout completes; watch whether higher strengths pull share from ZYN's 6mg users or cannibalize On!'s existing base.
  • Q4 2026: Blueberry Mint and Mango Pineapple hit shelves nationally; flavor variety has been a ZYN advantage, and On! is playing catch-up.
  • 2027: Line extensions leveraging the FDA authorization pathway; Altria has signaled this is a multi-year build, not a one-quarter fix.

The U.S. pouch market is a $7.3 billion freight train moving at 27% annual growth. On! is on board, but it's still looking for a seat closer to the front.

SOURCES:
Tobacco Insider: USA: Nicotine Pouches — August 2026 update
TobaccoIntelligence: Altria expands On! pouch range
PouchDaily: FDA Authorizes Four On! Nicotine Pouches

Compare prices: Check On! pouch prices across retailers at PouchFinder.